Labcorp and HealthEC Launch Transformative Oncology Care Module

Labcorp and HealthEC launch transformative oncology care module

BURLINGTON, N.C. & EDISON, N.J. --(BUSINESS WIRE)--Oct. 9, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and HealthEC, LLC , a leading provider of population health management solutions, today announced the launch of LabCorp’s Care Intelligence Oncology Module (Oncology Care Module). LabCorp’s Oncology Care Module is designed to empower oncologists to improve patient outcomes and achieve cost-savings by making it easier to access and compare key data points and performance metrics. Available exclusively through LabCorp , the single-platform solution connects claims and clinical systems using the LabCorp Care Intelligence™ application, powered by HealthEC®.

CLEAR adds LabCorp COVID-19 test results to “Health Pass” mobile app

NEW YORK & BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 5, 2020-- CLEAR, the secure identity company, and LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced a partnership to enable users of CLEAR’s Health Pass mobile app to securely link their LabCorp test results using their LabCorp Patient™ account. The partnership brings together LabCorp’s advanced testing capabilities, including its COVID-19 tests, with CLEAR’s safe and secure Health Pass technology.

LabCorp COVID-19 molecular test innovation receives FDA authorization

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 2, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced that it is the first commercial laboratory to receive an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a new, high-throughput method that uses heat and technology to extract RNA from samples collected for COVID-19 molecular testing. The advancement will help the company improve the speed and efficiency of RT-PCR tests, considered the ‘gold standard’ for active infections.1

19 Organizations from the healthcare community unite to form COVID-19 testing industry consortium

Consortium members will work together to increase opportunities to accelerate research through enhanced collaboration and information sharing, with the ultimate goal of improving aspects of COVID-19 testing across the globe.